Ipsen has announced the presentation of new study data on Dysport (abobotulinumtoxinA) in stroke and other neurological ...

Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...

Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Dry needling has emerged as a minimally invasive intervention utilised in neurorehabilitation to manage spasticity, particularly following stroke. This technique involves the insertion of fine needles ...

Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Departments of Veterans Affairs and Defense updated their clinical practice guidance for managing ...

A new and deceptively simple advance in chronic stroke treatment could be a vibrating glove. Researchers at Stanford University and Georgia Tech have developed a wearable device that straps around the ...

Public joins together for Community Gathering after fatal shooting at Brown University Providence City Council is inviting members of the public to a Community Gathering on Sunday to share support for ...

Spasticity is a condition that affects your muscles, making them tight or stiff. This can impact your ability to perform daily activities, such as walking, eating, and talking. The condition may also ...

Globally, stroke is the 2nd leading cause of death, and the 3rd leading cause of death and disability combined. While risk of stroke increases with age, the prevalence of stroke among adults over the ...

Complete list of Ipsen presentations at TOXINS 2026: ...